Dennis Gravekamp

Dennis Gravekamp

Auto-generated profile, based on publicly available information

Dennis Gravekamp

Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JSJorn E Stok
Jorn E Stok
TOTimo Oosenbrug
Timo Oosenbrug
LHLaurens R ter Haar
Laurens R ter Haar
DGDennis Gravekamp
Dennis Gravekamp
CBChristian Bromley
Christian Bromley
AVAnnemarthe G van der Veen
Annemarthe G van der Veen
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

8 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJorn E. Stok
Jorn E. Stok
SKSander B. van der Kooij
Sander B. van der Kooij
DGDennis Gravekamp
Dennis Gravekamp
LHLaurens R. ter Haar
Laurens R. ter Haar
JWJasper W. de Wolf
Jasper W. de Wolf
AVAnnemarthe G. van der Veen
Annemarthe G. van der Veen
Vault RNAs (vtRNAs) are a family of four small non-coding RNAs (ncRNAs) that are ubiquitously expressed in many eukaryotes and that regulate multiple cellular pathways. Their expression is increased upon infection with various DNA and RNA viruses. This suggests they are either co-opted by the virus to aid replication or function as an antiviral restriction factor. However, their precise molecular function remains unclear. Here, we show that replication of picornaviruses, alphaviruses, and beta-coronaviruses broadly enhances vtRNA expression. We find that genetic loss of vtRNAs inhibits replication of Sindbis virus (SINV) and encephalomyocarditis virus (EMCV), independent of the antiviral type I interferon (IFN) response. A proteomic screen uncovered the vtRNA interactome and revealed that vtRNAs associate with RNA binding proteins ELAVL1 and hnRNP C in uninfected and infected cells. VtRNAs facilitate the translocation of ELAVL1 and hnRNP C from the nucleus to the cytoplasm in infected cells, an event that is required for efficient viral replication. Moreover, hnRNP C and ELAVL1 fail to associate with viral RNA in the cytosol of SINV-infected cells in the absence of vtRNAs. Together, our findings reveal a novel molecular mechanism by which vtRNAs exert proviral activity during the course of SINV and EMCV infection, which opens up new avenues for therapeutic targeting to fight infectious diseases.

28 October 2021 in bioRxiv
Verified
Preprint
Open access
JSJorn E. Stok
Jorn E. Stok
TOTimo Oosenbrug
Timo Oosenbrug
LHLaurens R. ter Haar
Laurens R. ter Haar
DGDennis Gravekamp
Dennis Gravekamp
CBChristian Bromley
Christian Bromley
AVAnnemarthe G. van der Veen
Annemarthe G. van der Veen
RNA editing by the enzyme Adenosine Deaminase Acting on RNA 1 (ADAR1) is an important mechanism by which cells avoid innate immune responses to some endogenous RNAs. In ADAR1-deficient cells, unedited self RNAs can form base-paired structures that resemble viral RNAs and inadvertently activate antiviral innate immune pathways that lead to the induction of type I interferon (IFN). Rare mutations in ADAR1 cause Aicardi-Goutières Syndrome (AGS), a severe childhood autoinflammatory syndrome that is characterized by chronic and excessive type I IFN production and developmental delay. Conversely, ADAR1 dysfunction and consequent type I IFN production helps restrict tumor growth and potentiates the activity of some chemotherapy drugs. Induction of type I IFN in ADAR1-deficient cells is thought to be due to triggering of the cytosolic RIG-I-like receptor (RLR), MDA5, by unedited self RNAs. Here, we show that another RLR, LGP2, also has an essential role. We demonstrate that ADAR1-deficient human cells fail to mount a type I IFN response in the absence of LGP2 and this involves the canonical function of LGP2 as an RNA sensor and facilitator of MDA5-dependent signaling. Further, we show that the sensitivity of tumor cells to ADAR1 loss requires the presence of LGP2. Finally, we find that type I IFN induction in tumor cells depleted of ADAR1 and treated with some chemotherapeutics is fully dependent on the expression of LGP2. These findings highlight a central role for LGP2 in self RNA sensing with important clinical implications for the treatment of AGS as well as for the potential application of ADAR1-directed anti-tumor therapy.

3 November 2026 in bioRxiv
Verified
Preprint
Open access
LHLaurens R. ter Haar
Laurens R. ter Haar
SLSabine de Lange
Sabine de Lange
AKAnnick C. Kooij
Annick C. Kooij
DGDennis Gravekamp
Dennis Gravekamp
JWJasper W. de Wolf
Jasper W. de Wolf
AVAnnemarthe G. van der Veen
Annemarthe G. van der Veen
Self-derived double-stranded RNA (self-dsRNA) acts as potent triggers of autoinflammation and damage-associated molecular patterns in cancer and infection. However, the upstream processes controlling self-dsRNA homeostasis remain unclear. We uncover a non-canonical role for human Dicer in driving cell-intrinsic immunity to self-dsRNAs that arise from editing or splicing defects, epigenetic deregulation or mitochondrial stress. Dicer loss abolishes type-I interferon induction, PKR activation, and OAS-RNase L activation in response to self – but not exogenous – dsRNA in multiple cell types, including a clinically-relevant hiPSC model of neuroinflammation. Dicer interacts with G3BP1 and LGP2 to regulate self-dsRNA availability and recognition, respectively, independently of miRNAs. As immunostimulatory self-dsRNAs fail to accumulate and activate dsRNA sensors in absence of Dicer, these findings position Dicer as a central regulator of self-dsRNA sensing. Summary figure: Self-derived dsRNAs are potent triggers of innate immune activation that accumulate due to cellular dysfunction, such as mitochondrial stress, epigenetic deregulation or editing and splicing defects. Dicer and G3BP1 are jointly required for the cytosolic accumulation of self-dsRNA, and the activation of downstream innate immune dsRNA sensors, including Dicer interactors LGP2 and PKR. Self-dsRNA driven inflammation occurs in diverse pathological contexts – including neurodegeneration, autoimmunity, and cancer – thus making Dicer and its interactors promising targets for therapeutic intervention. Created in BioRender. Ter haar, L. (2025) https://BioRender.com/40ztdl0

1 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TOTimo Oosenbrug
Timo Oosenbrug
DGDennis Gravekamp
Dennis Gravekamp
APAdan Pinto-Fernandez
Adan Pinto-Fernandez
SCStefania Crotta
Stefania Crotta
KFKatja Finsterbusch
Katja Finsterbusch
AVAnnemarthe G. van der Veen
Annemarthe G. van der Veen
RIG-I-like receptors (RLRs) are cytoplasmic RNA sensors that promote type I and type III interferon (IFN) production in response to RNA ligands of viral or endogenous origin. The RLR pathway is tightly regulated by dynamic post-translational modifications, including ubiquitination. Huwe1 is a HECT domain-containing giant ubiquitin E3 ligase that has not been implicated in the RLR or IFN pathway. Here, we investigated whether Huwe1 is required for type I IFN induction downstream of RLRs. We demonstrate that loss of Huwe1 severely attenuates the expression of IFN-β, IFN-λ1 and IFN-stimulated genes (ISGs) in ADAR1-deficient human cells and primary murine bone-marrow derived macrophages, in which unedited self RNAs that serve as RLR ligands accumulate. In addition, depletion of Huwe1 reduces the induction of type I and III IFNs upon transfection with synthetic viral RNA mimetics or infection with a picornavirus. Using proteomics, we identified several putative Huwe1 substrates, which include key components of the RLR pathway (MAVS, TRAFs). We demonstrate that these substrates interact with Huwe1 and that Huwe1 is essential for the activity of TRAF5 in type I IFN induction. Collectively, our results put Huwe1 on the map as an important ubiquitin E3 ligase in the RLR pathway and provide new insights into ubiquitin-dependent regulation of cell-intrinsic antiviral immune pathways.